- Home
- COGT vs WRLD Comparison
COGT vs WRLD Comparison
Compare COGT & WRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- WRLD
- Stock Information
- Founded
- COGT 2014
- WRLD 1962
- Country
- COGT United States
- WRLD United States
- Employees
- COGT N/A
- WRLD N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- WRLD Finance: Consumer Services
- Sector
- COGT Health Care
- WRLD Finance
- Exchange
- COGT Nasdaq
- WRLD Nasdaq
- Market Cap
- COGT 1.1B
- WRLD 859.5M
- IPO Year
- COGT 2018
- WRLD 1991
- Fundamental
- Price
- COGT $12.36
- WRLD $167.83
- Analyst Decision
- COGT Strong Buy
- WRLD
- Analyst Count
- COGT 11
- WRLD 0
- Target Price
- COGT $21.20
- WRLD N/A
- AVG Volume (30 Days)
- COGT 1.5M
- WRLD 34.4K
- Earning Date
- COGT 11-11-2025
- WRLD 10-24-2025
- Dividend Yield
- COGT N/A
- WRLD N/A
- EPS Growth
- COGT N/A
- WRLD 10.95
- EPS
- COGT N/A
- WRLD 14.92
- Revenue
- COGT N/A
- WRLD $567,706,032.00
- Revenue This Year
- COGT N/A
- WRLD N/A
- Revenue Next Year
- COGT N/A
- WRLD $3.55
- P/E Ratio
- COGT N/A
- WRLD $11.56
- Revenue Growth
- COGT N/A
- WRLD 0.80
- 52 Week Low
- COGT $3.72
- WRLD $104.99
- 52 Week High
- COGT $13.50
- WRLD $177.25
- Technical
- Relative Strength Index (RSI)
- COGT 52.66
- WRLD 49.00
- Support Level
- COGT $12.28
- WRLD $164.91
- Resistance Level
- COGT $13.13
- WRLD $176.09
- Average True Range (ATR)
- COGT 0.52
- WRLD 4.33
- MACD
- COGT -0.08
- WRLD -0.76
- Stochastic Oscillator
- COGT 30.06
- WRLD 26.12
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About WRLD World Acceptance Corporation
World Acceptance Corp operates a small-loan consumer finance business. The company offers short-term small installment loans, medium-term larger installment loans, related credit insurance and ancillary products and services to individuals. It also offers income tax return preparation services to its loan customers and other individuals. The Company operates 1,024 branches in Alabama, Georgia, Idaho, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Missouri, New Mexico, Oklahoma, South Carolina, Texas, Tennessee, Utah, and Wisconsin.